Mechanism of release of alpha-methylated noradrenaline analogues by monoamine oxidase inhibitors.
D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D005260:Female; D006834:Hydrazines / Q000494:pharmacology*; D008680:Metaraminol / Q000378:metabolism; D008745:Methylation; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009474:Neurons; D009526:Nialamide / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000378:metabolism*; D014316:Tritium
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D014316:Tritium; D012701:Serotonin; D008680:Metaraminol; D009526:Nialamide; D004298:Dopamine; D009638:Norepinephrine